Macromolecular Rapid Communications,
Journal Year:
2019,
Volume and Issue:
40(10)
Published: March 5, 2019
Abstract
Stimuli‐responsive
nanoparticles
have
the
potential
to
improve
delivery
of
therapeutics
a
specific
cell
or
region
within
body.
There
are
many
stimuli
that
shown
for
release
cargo,
including
variation
pH,
redox
potential,
presence
enzymes.
pH
has
generated
significant
interest
synthesis
stimuli‐responsive
because
internalized
into
cells
via
vesicles
acidified.
Additionally,
tumor
microenvironment
is
known
lower
than
surrounding
tissue.
In
this
review,
different
strategies
design
pH‐responsive
discussed,
focusing
on
use
charge‐shifting
polymers,
acid
labile
linkages,
and
crosslinking.
Nano Letters,
Journal Year:
2016,
Volume and Issue:
16(9), P. 5401 - 5408
Published: Aug. 4, 2016
Chemotherapeutic
efficacy
can
be
greatly
improved
by
developing
nanoparticulate
drug
delivery
systems
(nano-DDS)
with
high
loading
capacity
and
smart
stimulus-triggered
release
in
tumor
cells.
Herein,
we
report
a
novel
redox
dual-responsive
prodrug-nanosystem
self-assembled
hydrophobic
small-molecule
conjugates
of
paclitaxel
(PTX)
oleic
acid
(OA).
Thioether
linked
(PTX-S-OA)
dithioether
inserted
(PTX-2S-OA)
are
designed
to
respond
the
redox-heterogeneity
tumor.
Dithioether
has
been
reported
show
dual-responsiveness,
but
find
that
PTX-S-OA
exhibits
superior
sensitivity
over
PTX-2S-OA,
achieving
more
rapid
selective
free
PTX
from
prodrug
nanoassemblies
triggered
stimuli.
PEGylated
nanoassemblies,
impressively
(57.4%),
exhibit
potent
antitumor
activity
human
epidermoid
carcinoma
xenograft.
This
addresses
concerns
related
low
inefficient
prodrugs
PTX,
provides
possibilities
for
development
dual-sensitive
or
polymers
efficient
anticancer
delivery.
Chemical Reviews,
Journal Year:
2019,
Volume and Issue:
119(24), P. 12208 - 12278
Published: Dec. 3, 2019
Plasmonic
nanostructures
possessing
unique
and
versatile
optoelectronic
properties
have
been
vastly
investigated
over
the
past
decade.
However,
full
potential
of
plasmonic
nanostructure
has
not
yet
fully
exploited,
particularly
with
single-component
homogeneous
structures
monotonic
properties,
addition
new
components
for
making
multicomponent
nanoparticles
may
lead
to
new-yet-unexpected
or
improved
properties.
Here
we
define
term
"multi-component
nanoparticles"
as
hybrid
composed
two
more
condensed
nanoscale
domains
distinctive
material
compositions,
shapes,
sizes.
We
reviewed
discussed
designing
principles
synthetic
strategies
efficiently
combine
multiple
form
a
functionality.
In
particular,
it
quite
challenging
precisely
synthesize
widely
diverse
structures,
limiting
realization
heterostructures.
To
address
this
challenge,
several
approaches
reported
variety
different
nanoparticles,
mainly
based
on
heterogeneous
nucleation,
atomic
replacements,
adsorption
supports,
biomolecule-mediated
assemblies.
addition,
synergistic
features
such
combination
pristine
finely
tuned
plasmon
resonance
coupling,
enhanced
light-matter
interactions,
geometry-induced
polarization,
plasmon-induced
energy
charge
transfer
across
heterointerface,
were
reported.
review,
comprehensively
summarize
latest
advances
state-of-art
strategies,
promising
applications
nanoparticles.
These
including
heterostructured
composite
are
prepared
by
direct
synthesis
physical
force-
assembly,
which
hold
tremendous
plasmon-mediated
transfer,
magnetic
plasmonics,
metamolecules,
nanobiotechnology.
Drug Delivery,
Journal Year:
2017,
Volume and Issue:
24(1), P. 539 - 557
Published: Jan. 1, 2017
Nanogels
in
biomedical
field
are
promising
and
innovative
materials
as
dispersions
of
hydrogel
nanoparticles
based
on
crosslinked
polymeric
networks
that
have
been
called
next
generation
drug
delivery
systems
due
to
their
relatively
high
encapsulation
capacity,
uniformity,
tunable
size,
ease
preparation,
minimal
toxicity,
stability
the
presence
serum,
stimuli
responsiveness.
show
a
great
potential
chemotherapy,
diagnosis,
organ
targeting
bioactive
substances.
The
main
subjects
reviewed
this
article
concentrates
on:
(i)
Nanogel
assimilation
nanomedicine
domain;
(ii)
Features
advantages
nanogels,
characteristics,
such
as:
swelling
sensitivity,
surface
area,
functionalization,
bioconjugation
substances,
which
taken
into
account
designing
structures
according
application;
some
data
limitations
preparation
techniques;
(iii)
Recent
progress
nanogels
carrier
genetic
material,
protein
vaccine.
majority
scientific
literature
presents
multivalency
bioconjugated
various
conditions.
Today's
research
focuses
over
overcoming
restrictions
imposed
by
cost,
medical
requirements
technological
issues,
for
nanogels'
commercial
scale
production
integration
new
platform
biomedicine.
Journal of the American Chemical Society,
Journal Year:
2017,
Volume and Issue:
139(13), P. 4584 - 4610
Published: Feb. 13, 2017
Nanotechnology
has
begun
to
play
a
remarkable
role
in
various
fields
of
science
and
technology.
In
biomedical
applications,
nanoparticles
have
opened
new
horizons,
especially
for
biosensing,
targeted
delivery
therapeutics,
so
forth.
Among
drug
systems
(DDSs),
smart
nanocarriers
that
respond
specific
stimuli
their
environment
represent
growing
field.
Nanoplatforms
can
be
activated
by
an
external
application
light
used
wide
variety
photoactivated
therapies,
light-triggered
DDSs,
relying
on
photoisomerization,
photo-cross-linking/un-cross-linking,
photoreduction,
addition,
activation
potential
photodynamic
therapy,
photothermal
radiotherapy,
protected
bioactive
moieties,
anticancer
systems,
theranostics
(i.e.,
real-time
monitoring
tracking
combined
with
therapeutic
action
different
diseases
sites
organs).
Combinations
these
approaches
lead
enhanced
synergistic
employing
as
trigger
or
activation.
Nonlinear
absorption
mechanisms
such
two-photon
photon
upconversion
been
employed
the
design
light-responsive
DDSs.
The
integration
stimulus
into
dual/multiresponsive
provide
spatiotemporal
controlled
release
agents,
nanosystems,
two
more
on-demand
under
conditions,
Overall,
light-activated
nanomedicines
DDSs
are
expected
effective
therapies
against
serious
cancers,
inflammation,
infections,
cardiovascular
disease
reduced
side
effects
will
open
doors
toward
treatment
patients
worldwide.